U.S. market Closed. Opens in 5 hours 20 minutes

SNTI | Senti Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.56M4.29M2.29M394.00K85.00K
Cost of Revenue5.24M3.92M3.01M15.96M14.52M
Gross Profit-2.68M366.00K-719.00K-15.56M-14.44M
Operating Expenses64.08M74.92M42.74M25.09M7.39M
Selling, General & Admin33.00M40.85M21.25M9.30M7.34M
Research & Development31.08M34.07M21.96M15.96M14.52M
Other Operating Expenses2.29M12.42M-470.00K-172.00KN/A
Operating Income-66.77M-70.63M-40.45M-24.69M-21.78M
Other Expenses / Income-16.64M12.42M-14.87M4.83M625.00K
Before Tax Income-83.41M-58.21M-55.32M-19.86M-21.16M
Income Tax Expenses9.51M-12.42M11.00K150.00KN/A
Net Income-71.06M-58.21M-55.32M-19.86M-21.16M
Interest ExpensesN/A-3.92MN/AN/AN/A
Basic Shares Outstanding4.44M2.61M4.37M4.37M13.59M
Diluted Shares Outstanding4.44M2.61M4.37M4.37M13.59M
EBITDA-61.52M-70.63M-37.41M-22.47M-21.36M
EBITDA Margin-2,402.23%-1,647.90%-1,633.09%-5,703.30%-25,123.53%
EBIT-61.55M-74.55M-55.31M-19.71M-21.16M
EBIT Margin-2,403.16%-1,739.36%-2,414.14%-5,003.05%-24,890.59%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙